Catalyst
Slingshot members are tracking this event:
Marinus Pharmaceuticals (MRNS) Receives Orphan Drug Designation From FDA on Ganaxolone in treating Fragile X Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MRNS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 03, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ganaxolone Iv, Orphan Drug
